TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MENA ALLERGY DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 PRODUCT TIMELINE CURVE
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING ENVIRONMENTAL POLLUTION LEVELS
3.1.2 HIGH INCIDENCE OF ALLERGIC DISEASES
3.1.3 INCREASING HEALTHCARE EXPENDITURE
3.2 RESTRAINTS
3.2.1 LACK AWARENESS OF ALLERGY DISEASES
3.2.2 HIGH COST OF ALLERGY TEST, TESTING KITS AND DIAGNOSTICS PRODUCT
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGY ADVANCEMENT
3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
3.4 CHALLENGES
3.4.1 LACK OF SKILLED PROFESSIONALS
3.4.2 STRICT REGULATORY POLICY
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
?
6 MENA ALLERGY DIAGNOSTICS MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 ASSAY KITS
6.2.1 ELISA KITS
6.2.2 AGRASTRIP
6.2.3 RAPID TEST EASY KIT
6.2.4 OTHERS
6.3 INSTRUMENTS
6.3.1 ELISA ANALYZERS
6.3.2 IMMUNOASSAY ANALYZERS
6.3.3 LATERAL FLOW DEVICES
6.3.4 LUMINOMETERS
6.3.5 OTHERS
6.4 CONSUMABLES
6.5 SERVICES
7 MENA ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN
7.1 OVERVIEW
7.2 ANTIBIOTICS, OTHER DRUGS AND CHEMICALS ALLERGENS
7.3 FOOD ALLERGENS
7.4 INHALED ALLERGENS
7.5 OCCUPATIONAL ALLERGENS
7.6 CONTACT ALLERGENS
7.7 MISCELLANEOUS PLANT ALLERGENS
7.8 OTHERS
8 MENA ALLERGY DIAGNOSTICS MARKET, BY TEST
8.1 OVERVIEW
8.2 IN-VIVO TEST
8.2.1 BLOOD TESTS/RADIOALLERGOSORBENT TESTS (RAST)
8.2.1.1 TOTAL IGE
8.2.1.2 CAST TESTING/ SPECIFIC IGE
8.2.2 MULTI-ALLERGEN IGE ANTIBODY SCREENING ASSAYS
8.2.3 MAST CELL TRYPTASE
8.2.4 OTHERS
8.3 IN-VITRO TEST
8.3.1 SKIN-PRICK TESTING
8.3.2 INTRADERMAL SKIN TESTS
8.3.3 SCRATCH TEST
8.3.4 OTHERS
9 MENA ALLERGY DIAGNOSTICS MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC LABORATORIES
9.3 HOSPITALS
9.4 ACADEMIC RESEARCH LABORATORIES
9.5 OTHERS
10 MENA ALLERGY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT
10.3 INDIRECT
11 MENA, ALLERGY DIAGNOSTICS MARKET GEOGRAPHY
11.1 MENA
1.1.1. SAUDI ARABIA
1.1.2. UAE
1.1.3. EGYPT
1.1.4. ISRAEL
1.1.5. KUWAIT
1.1.6. NORTH AFRICA
1.1.7. REST OF MENA
12 MENA ALLERGY DIAGNOSTICS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MENA
13 COMPANY PROFILE
13.1 OMEGA DIAGNOSTICS GROUP PLC
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 SIEMENS HEALTHINEERS AG
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 R-BIOPHARM AG
13.3.1 COMPANY SNAPSHOT
13.3.2 PRODUCT PORTFOLIO
13.3.3 RECENT DEVELOPMENT
?
13.4 THERMO FISHER SCIENTIFIC INC
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 PERKINELMER INC.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 BIOMÉRIEUX SA
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 RECENT DEVELOPMENT
13.7 HITACHI, LTD
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 INDOOR BIOTECHNOLOGIES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 SERVICE PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 QUEST DIAGNOSTICS INCORPORATED
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.10 ROXALL MEDIZIN GMBH
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS